FDA Plans to Hold the First Hearing on the Regulation of Cannabidiol

The FDA is going to have its first hearing on the regulation of CBD or cannabidiol on Friday. It takes place among the craze for CBD products such as potions, lotions, gummies, capsules, and oils.

The goal of the meeting is to collect info on a variety of topics associated with products loaded with these components. A lot of interested parties will speak in the hearing, including consumers, doctors, and cannabis firms.

In fact, CBD doesn’t cause users to get “high. Many people have been inhaling or ingesting CBD as recreational marijuana for years. What is different now is the fact that CBD is isolated as a compound and added to different products and supplements, which results in many questions to its safety.

“We really do not know anything about the safety,” said a drug expert at Harvard University. “Our country still doesn’t have any mechanism to control supplements effectively and guarantee that they are safe to use.”

Those products are often promoted as great ways to deal with different health issues such as chronic pain, anxiety, and insomnia. However, most of these claims are still unsupported. Indeed, there might be some possible harmful effects.

“Many people tend to avoid truly effective options since they believe that CBD would help them,” said Dr. Peter Lurie, the president of a consumer watchdog organization.

Supplement firms are trying to urge the FDA to take action on the regulation of CBD-containing products. “We are concerned that there are many companies that just make use of the current situation rather understanding what they are doing.”

The financial effects are significant enormous. It is estimated that CBD sales in the United States are expected to reach around $20 billion in 2024.

The market started taking off in 2018 after Congress introduced a new law that removes hemp from the list of controlled substances. However, CBD, a derivative from hemp, is still regulated by the FDA.

The purpose of the hearing on Friday is only to collect the necessary information. This means that there will be no official decisions would be made by the FDA. It might take many years to put any form of CBD regulation in place, which might frustrate plenty of industry insiders.

Many CBD manufacturers and distributors are still waiting as they want to comply with the law. In other words, they are hoping for a new framework so that they would legally and legitimately create high-quality products that contain CBD.

Source:

https://edition.cnn.com/2019/05/31/health/cbd-hearing-fda/index.html

Related Articles

Osteoporosis Diet & Nutrition – Foods for Bone Health

Diet & Nutrition
It is very important to build healthy bones, especially in people with osteoporosis. This condition reduces bone density and makes them more vulnerable to...

Pneumonia Diagnosis & Treatments

Your Health
Pneumonia is a common infection that causes inflamed air sacs in your lungs. These areas might be filled with pus or fluid, making it...

Guide on Getting A Colonoscopy

Ailments & Conditions
Colonoscopy Overview: A colonoscopy is a medical procedure or exam to check for abnormalities present in the colon (large intestine) and the rectum. It can be...

12 Apple Cider Vinegar Health Benefits

Diet & Nutrition
Apple cider vinegar is a type of liquid which is produced from the fermentation of sugar in apples thanks to bacteria and yeast. Just...

The 10 Best Types of Cat

Featured
Cats are definitely one of the most popular pets all over the world. Having a feline friend in the family may bring a lot...

Top 7 Causes of Dry Mouth (Xerostomia)

Ailments & Conditions
The things we should avoid doing as humans are jumping to conclusions or being quick to judge. You sit beside a person, or you...

10 Facts of Inositol to Know

Diet & Nutrition
Inositol or vitamin B8 is an important substance for many body functions. It naturally occurs in some foods, such as nuts, grains, beans, and...

Treatments for Relapsed Multiple Myeloma

Your Health
Multiple myeloma is a severe condition that affects plasma cells or white blood cells in the bone marrow. While there are many treatment options,...